Advertisement
As low-volume facilities continue to seek efficiency-enhancing solutions,the ci4100 is designed to deliver improved productivity by providing a largecapacity of up to 85 onboard reagents and 180 samples that can be continuouslyloaded and unloaded during the testing process. The ci4100 also willeffectively integrate clinical chemistry and immunoassay testing with anexpansive test menu, while maintaining quick and consistent immediateturnaround times during both peak and off-peak hours. This helps low tomid-volume facilities meet the demands of increasing workloads and clinicalrequirements. The ci4100 can generate up to 800 clinical chemistry and 100immunoassay tests per hour.
Advertisement
When available in the United States, the ci4100 will complete theARCHITECT family of analyzers. The ARCHITECT system integrates two highlysuccessful ARCHITECT instruments: the i1000SR immunoassay analyzer and thec4000 clinical chemistry system, which was developed with Abbott's partner,Toshiba. Because the ci4100 is based on Abbott's existing ARCHITECT ci8200and ci16200 integrated platforms, it shares common hardware, software andreagents. Upon regulatory approval, Abbott will be the only company offeringhigh, medium and low-volume integrated solutions leveraging the same software,reagents and sample carriers.
The AACC Annual Meeting is a global meeting that attracts nearly 20,000attendees from more than 100 countries. The ci4100 is on display in Abbott'sAACC exhibit booth (No. 1507).
About the ARCHITECT Family
With its extensive menu of diagnostic tests, user-friendly software andadvanced sample management capabilities, the ARCHITECT family and thecurrently marketed flagship analyzer, ARCHITECT(R) ci8200(R), meet the needsof today's diagnostics laboratory by enhancing workflow and productivity.
ARCHITECT instruments are designed with laboratory-focused features suchas the capability to prioritize emergency tests, the ability to use commonreagents among platforms and sample monitoring. These features not onlyminimize training, but also reduce inventory costs and sample contaminationpotential, leading to better results for laboratories, physicians and,ultimately, patients.
About Abbott's Diagnostics Businesses
Abbott is a global leader in in vitro diagnostics and offers a broad rangeof innovative instrument systems and tests for hospitals, reference labs,molecular labs, blood banks, physician offices and clinics. With more than65,000 customers in more than 100 countries, Abbott's diagnostic productsoffer customers automation, convenience, bedside testing, cost effectivenessand flexibility. Abbott has helped transform the practice of medical diagnosisfrom an art to a science through the company's commitment to improving patientcare and lowering costs. The history of Abbott is filled with examples offirst-of-a-kind diagnostic products and significant technological and researchadvancements.
About Abbott
Abbott is a global, broad-based health care company devoted to thediscovery, development, manufacture and marketing of pharmaceuticals andmedical products, including nutritionals, devices and diagnostics. Thecompany employs more than 68,000 people and markets its products in more than130 countries.
Abbott's news releases and other information are available on thecompany
